Delaware | 001-35210 | 54-1708481 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
450 Park Avenue, 30th Floor | ||
New York, NY 10022 | ||
(Address of principal executive offices) | ||
(212) 235-2690 | ||
(Registrant’s telephone number, including area code) | ||
Not Applicable | ||
(Former name or former address, if changed since last report.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Exhibit No. | |
99.1 | |
99.2 | |
99.3 | |
99.4 |
HC2 Holdings, Inc. | |
(Registrant) | |
By: | /s/ Michael J. Sena |
Name: Michael J. Sena | |
Title: Chief Financial Officer |
Page | |||
Financial Statements | |||
Consolidated Balance Sheets................................................................................................................................................. | 1 | ||
Consolidated Statements of (Loss) Income........................................................................................................................... | 2 | ||
Consolidated Statements of Comprehensive (Loss) Income................................................................................................. | 3 | ||
Consolidated Statements of Stockholders' Equity................................................................................................................. | 4 | ||
Consolidated Statements of Cash Flows............................................................................................................................... | 5 | ||
Notes to Consolidated Financial Statements......................................................................................................................... | 6 |
June 30, 2018 | December 31, 2017 | ||||
Assets | |||||
Investments | |||||
Debt securities, available for sale | $ | 1,553,702,313 | $ | 2,289,882,280 | |
Policy loans | 2,965,058 | 10,643,668 | |||
Mortgage loans | 943,151 | 1,215,866 | |||
Restricted assets | 19,434,856 | 52,877,093 | |||
Total investments | 1,577,045,378 | 2,354,618,907 | |||
Cash and cash equivalents | 578,216,966 | 205,278,804 | |||
Receivables, less allowance for doubtful accounts of $232,153 in 2018 and $943,345 in 2017 | 2,328,304 | 2,896,967 | |||
Current income tax receivable | 2,280,609 | 6,332,420 | |||
Intangible assets, less accumulated amortization of $2,592,898 in 2018 and $29,103,795 in 2017 | 1,082,103 | 10,932,980 | |||
Deferred policy acquisition costs | 0 | 73,646,222 | |||
Reinsurance recoverable | 817,843,338 | 559,058,512 | |||
Prepaid reinsurance asset | 55,909,710 | 0 | |||
Noncurrent deferred income tax assets | 168,812,182 | 170,071,803 | |||
Other assets | 63,747,765 | 29,062,073 | |||
Total assets | $ | 3,267,266,355 | $ | 3,411,898,688 | |
Liabilities | |||||
Benefits payable | $ | 58,002,358 | $ | 54,375,146 | |
Future policy benefits payable | 2,622,978,375 | 2,761,703,267 | |||
Advance premiums | 3,792,063 | 4,046,277 | |||
Accounts payable and accrued expenses | 6,629,957 | 11,204,463 | |||
Book overdraft | 3,546,499 | 5,927,904 | |||
Due to Humana Inc. | 3,270,707 | 5,119,963 | |||
Other liabilities | 5,964,057 | 920,894 | |||
Total liabilities | 2,704,184,016 | 2,843,297,914 | |||
Stockholders’ Equity | |||||
Common stock, $0.01 par value; 1,000 shares authorized, issued, and outstanding | 10 | 10 | |||
Capital in excess of par value | 1,667,487,126 | 1,667,487,126 | |||
Retained deficit | (1,092,104,707) | (1,125,699,875) | |||
Accumulated other comprehensive (loss) income | (12,300,090) | 26,813,513 | |||
Total stockholders’ equity | 563,082,339 | 568,600,774 | |||
Total liabilities and stockholders’ equity | $ | 3,267,266,355 | $ | 3,411,898,688 |
Three months ended June 30, | Six months ended June 30, | ||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||
Direct premiums | $ | 37,913,312 | $ | 41,373,774 | $ | 82,119,131 | $ | 85,062,898 | |||
Assumed premiums | 1,069,690 | 910,075 | 1,759,387 | 1,504,203 | |||||||
Ceded premiums | (10,806,526) | (3,832,029) | (14,379,049) | (7,508,178) | |||||||
Net premiums | 28,176,476 | 38,451,820 | 69,499,469 | 79,058,923 | |||||||
Net investment and interest income | 65,057,441 | 24,834,339 | 102,601,716 | 52,522,895 | |||||||
Other revenue | 1,716 | 1,475 | 5,205 | 3,057 | |||||||
Total revenue | 93,235,633 | 63,287,634 | 172,106,390 | 131,584,875 | |||||||
Direct benefits expense | 61,034,930 | 53,609,588 | 113,165,746 | 105,715,639 | |||||||
Assumed benefits expense | (1,236,778) | 423,702 | 935 | 2,215,028 | |||||||
Ceded benefits expense | (12,847,840) | (10,664,514) | (24,334,340) | (19,203,123) | |||||||
Net benefits expense | 46,950,312 | 43,368,776 | 88,832,341 | 88,727,544 | |||||||
Selling, general and administrative expenses | 11,694,070 | 16,284,987 | 25,551,117 | 36,093,632 | |||||||
Commission and expense allowance on reinsurance ceded | (3,247,627) | (528,069) | (3,740,772) | (1,039,520) | |||||||
Depreciation and amortization expenses | 4,265,733 | 10,287,072 | 9,948,651 | 17,968,200 | |||||||
Total expenses | 59,662,488 | 69,412,766 | 120,591,337 | 141,749,856 | |||||||
Income (loss) before provision (benefit) for income taxes | 33,573,145 | (6,125,132) | 51,515,053 | (10,164,981) | |||||||
Provision (benefit) for income taxes | 8,016,376 | (2,365,445) | 12,229,723 | (3,912,026) | |||||||
Net income (loss) | $ | 25,556,769 | $ | (3,759,687) | $ | 39,285,330 | $ | (6,252,955) |
Three months ended June 30, | Six months ended June 30, | ||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||
Net income (loss) | $ | 25,556,769 | $ | (3,759,687) | $ | 39,285,330 | $ | (6,252,955) | |||
Other comprehensive (loss) income | |||||||||||
Changes in gross unrealized investment gains (losses) | 28,409,630 | 13,042,518 | (4,583,410) | 14,049,395 | |||||||
Effect of income taxes | (6,696,150) | (4,819,210) | 1,080,310 | (5,191,252) | |||||||
Total change in unrealized investment gains (losses), net of tax | 21,713,480 | 8,223,308 | (3,503,100) | 8,858,143 | |||||||
Reclassification adjustment for net realized gains included in net investment and interest income | (41,399,569) | (954,482) | (54,037,243) | (6,434,383) | |||||||
Effect of income taxes | 9,757,878 | 352,681 | 12,736,578 | 2,377,505 | |||||||
Total reclassification adjustment, net of tax | (31,641,691) | (601,801) | (41,300,665) | (4,056,878) | |||||||
Other comprehensive (loss) income, net of tax | (9,928,211) | 7,621,507 | (44,803,765) | 4,801,265 | |||||||
Comprehensive income (loss) | $ | 15,628,558 | $ | 3,861,820 | $ | (5,518,435) | $ | (1,451,690) |
Common Stock | Accumulated Other Comprehensive (Loss) Income | ||||||||||||||
Shares | Amount | Capital in excess of par value | Retained Deficit | Total Stockholders’ Equity | |||||||||||
Balances at January 1, 2017 | 1,000 | $ 10 | $ | 1,132,487,126 | $ | (1,008,111,524) | $ | 3,528,943 | $ | 127,904,555 | |||||
Net loss | 0 | 0 | 0 | (117,588,351) | 0 | (117,588,351) | |||||||||
Capital contribution | 535,000,000 | 0 | 0 | 535,000,000 | |||||||||||
Other comprehensive income | 0 | 0 | 0 | 0 | 23,284,570 | 23,284,570 | |||||||||
Balances at December 31, 2017 | 1,000 | 10 | 1,667,487,126 | (1,125,699,875) | 26,813,513 | 568,600,774 | |||||||||
Net income | 0 | 0 | 0 | 39,285,330 | 0 | 39,285,330 | |||||||||
Tax rate change remeasurement effect | 0 | 0 | 0 | (5,690,162) | 5,690,162 | 0 | |||||||||
Other comprehensive loss | 0 | 0 | 0 | 0 | (44,803,765) | (44,803,765) | |||||||||
Balances at June 30, 2018 | 1,000 | $ 10 | $ | 1,667,487,126 | $ | (1,092,104,707) | $ | (12,300,090) | $ | 563,082,339 |
For the six months ended June 30, | |||||
2018 | 2017 | ||||
Cash flows from operating activities | |||||
Net income (loss) | $ | 39,285,330 | $ | (6,252,955) | |
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities | |||||
Depreciation and amortization expense | 9,948,651 | 17,968,200 | |||
Deferred income tax provision | 15,076,510 | 1,215,594 | |||
Amortization on investments | 1,013,172 | 1,361,557 | |||
Net realized capital gains | (54,037,243) | (6,434,383) | |||
Amortization of prepaid reinsurance asset | 825,357 | 0 | |||
Changes in operating assets and liabilities | |||||
Premium receivables | 568,663 | 3,223,588 | |||
Income tax receivable/payable | 4,051,811 | 8,036,013 | |||
Reinsurance receivables | (294, 229,181) | (8,683,227) | |||
Deferred policy acquisition costs | (3,651,973) | (6,687,403) | |||
Prepaid reinsurance asset | 55,909,710 | 0 | |||
Prepaid expenses and other assets | 15,890,781 | (2,419,187) | |||
Benefits payable | 3,627,211 | 1,672,942 | |||
Future policy benefits payable | 29,601,053 | 28,427,071 | |||
Accounts payables and accrued expenses | (4,574,507) | (1,774,093) | |||
Due to/from Humana Inc. | (1,849,102) | (11,818,131) | |||
Advance premiums | (254,213) | 416,164 | |||
Other liabilities | 5,043,164 | (220,407) | |||
Total adjustments | (217,040,136) | 24,284,298 | |||
Net cash (used in) provided by operating activities | (177,754,806) | 18,031,343 | |||
Cash flows from investing activities | |||||
Proceeds from sales of investment securities | 606,972,716 | 99,286,473 | |||
Proceeds from maturities of investment securities | 22,742,604 | 25,026,867 | |||
Purchases of investment securities | (76,640,947) | (502,653,465) | |||
Purchases of property and equipment | 0 | (854) | |||
Net cash provided by (used in) investing activities | 553,074,373 | (378,340,979) | |||
Cash flows from financing activities | |||||
Capital contribution received | 0 | 535,000,000 | |||
Change in book overdraft | (2,381,405) | 381,252 | |||
Net cash (used in) provided by financing activities | (2,381,405) | 535,381,252 | |||
Increase in cash and cash equivalents | 372,938,162 | 175,071,616 | |||
Cash and cash equivalents | |||||
Beginning of period | 205,278,804 | 32,676,298 | |||
End of period | $ | 578,216,966 | $ | 207,747,914 | |
Income taxes recovered (paid) | $ | 6,898,599 | $ | (13,163,634 | ) |
1. | Reporting Entity |
2. | Summary of Significant Accounting Policies |
a. | Cash and Cash Equivalents: Cash and cash equivalents include cash, certificates of deposit, money market funds and commercial paper each with an original maturity of three months or less. The carrying value of cash equivalents investments approximates fair value due to the short-term maturity of the investments. |
b. | Restricted Assets: The Company is required by regulatory agencies to set aside statutory deposits to comply with laws of the various states in which it operates. These funds are classified as restricted assets in the accompanying consolidated balance sheets. These statutory deposits are available for payment of medical claims should the Company become insolvent. |
2018 | 2017 | ||||
Florida | $ | 2,543,625 | $ | 2,608,850 | |
Georgia | 25,000 | 50,056 | |||
Massachusetts | 596,625 | 598,110 | |||
New Hampshire | 495,879 | 0 | |||
New Mexico | 106,407 | 107,911 | |||
North Carolina | 399,652 | 399,278 | |||
South Carolina | 0 | 2,048,729 | |||
South Dakota | 198,875 | 199,370 | |||
Virginia | 522,047 | 523,346 | |||
Total statutory deposits | $ | 4,888,110 | $ | 6,535,650 |
c. | Book Overdraft: Under the Company’s cash management arrangement with Humana, checks issued but not yet presented to banks frequently result in overdraft balances at the legal entity level as cash is concentrated at the parent company level. In accordance with the Company’s intercompany agreements with Humana, funding is available and payment is guaranteed on these outstanding checks and will be swept from the consolidated account as needed. As such, the outstanding payments are reclassified to a liability and generally settled within 30 days. At June 30, 2018 and December 31, 2017 the book overdraft was $3,546,499 and $5,927,904, respectively. |
d. | Investment Securities: Investment securities, which consist entirely of debt securities, have been categorized as available for sale and, as a result, are stated at fair value. Fair value of publicly traded debt securities is based on quoted market prices. Income from investments is recorded on an accrual basis. For the purpose of determining gross realized gains and losses, which are included as a component of net investment and interest income in the statements of income, the cost of investment securities sold is based upon specific identification. Unrealized holding gains and losses, net of applicable deferred taxes, are included as a component of stockholders’ equity and comprehensive income (loss) until realized from a sale or other-than-temporary impairment (OTTI). The Company regularly evaluates its investment securities for impairment. |
e. | Premiums: The Company bills and collects premium from members monthly. Premiums are estimated by multiplying membership covered under contracts by contractual rates. Premiums are recognized as income in the period members are entitled to receive services, and are net of estimated uncollectible amounts and retroactive membership adjustments. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by the government. The Company routinely monitors the collectability of specific accounts, the aging of receivables, historical retroactivity trends, as well as prevailing and anticipated economic conditions, and reflects any required adjustments in current operations. Premiums received prior to the service period are recorded as advance premiums. |
f. | Benefits Payable and Benefits Expense: Benefits payable represents management’s best estimate of the ultimate net cost of all reported and unreported claims incurred through June 30, 2018 and December 31, 2017. Benefits payable is estimated using individual case-basis valuations and statistical analyses. Those estimates are subject to the effects of trends in claim severity and frequency. Although considerable variability is inherent in such estimates, management believes that the benefit payables are adequate. The estimates are continually reviewed and adjusted as necessary experience develops or new information becomes known, such adjustments are included in current operations. |
g. | Deferred Policy Acquisition Costs: Policy acquisition costs are those costs that relate directly to the successful acquisition of new and renewal insurance policies. Such costs include commissions, costs of policy issuance and underwriting, and other costs incurred to acquire new business or renew existing business. |
h. | Intangible Assets: Value of business acquired (VOBA) is the value assigned to the insurance in force of acquired insurance companies or blocks of insurance business at the date of acquisition and is included in intangible assets as of December 31, 2017. There was no VOBA as of June 30, 2018 as further discussed in Note 2j. The amortization of value of business acquired is recognized using amortization schedules established at the time of the acquisitions based upon expected annual premium. Certain amortization schedules include actual to expected adjustments to reflect actual experience as it emerges. The value of business acquired is amortized over the premium-paying period of the policies. |
i. | Future Policy Benefits Payable: Future policy benefits payable include liabilities for long-duration insurance policies including long-term care, life insurance, annuities, and certain health and other supplemental policies sold to individuals for which some of the premium received in the earlier years is intended to pay anticipated benefits to be incurred in future years. At policy issuance, these reserves are recognized on a net level premium method based on interest rates, mortality, morbidity, and maintenance expense assumptions. Interest rates are based on expected net investment returns on the investment portfolio supporting the reserves for these blocks of business. Mortality, a measure of expected death, and morbidity, a measure of health status, assumptions are based on published actuarial tables, modified based upon actual experience. Changes in estimates of these reserves are recognized as an adjustment to benefits expense in the period the changes occur. The Company performs loss recognition tests at least annually in the fourth quarter, and more frequently if adverse events or changes in circumstances indicate that the level of the liability, together with the present value of future gross premiums, may not be adequate to provide for future expected policy benefits and maintenance costs. |
j. | Reinsurance: The Company reinsures portions of its business through various reinsurance treaties. These treaties protect the Company from sustaining losses above predetermined levels and are included as a reduction of direct premiums in the accompanying consolidated statements of operations. Although the reinsurer in each case is primarily liable on the insurance ceded, the Company remains liable to the insured whether or not the reinsurer meets its contractual obligations. The Company also has reinsurance assumed agreements which are included as an addition to direct premiums in the accompanying consolidated statements of operations. The Company had a reinsurance contract with an affiliate. |
k. | Income Taxes: The Company recognizes an asset or liability for the deferred tax consequences of temporary differences between the tax basis of assets or liabilities and their reported amounts in the financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. The Company also recognizes the future tax benefits such as net operating and capital carryforwards as deferred tax assets. A valuation allowance is provided against these deferred tax assets if it is more likely than not that some position or all of the deferred tax assets will not be realized. Future years’ tax expense may be increased or decreased by adjustments to the valuation allowance or to the estimated accrual for income taxes. Deferred tax assets and deferred tax liabilities are further adjusted for changes in the enacted tax rates. |
l. | Fair Value: Assets and liabilities measured at fair value are categorized into a fair value hierarchy based on whether the inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company’s own assumptions about the assumptions market participants would use. The fair value hierarchy includes three levels of inputs that may be used to measure fair value as described below. |
Level 1 | Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include debt securities that are traded in an active exchange market. |
Level 2 | Observable inputs other than Level 1 prices such as quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments as well as debt securities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data. |
Level 3 | Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting the Company’s own assumptions about the assumptions market participants would use as well as those requiring significant management judgment. |
m. | Long-Lived Assets: Property and equipment is recorded at cost. Gains and losses on sales or disposals of property and equipment are included in selling, general and administrative expenses. Depreciation is computed using the straight-line method over estimated useful lives ranging from 3 to 10 years for equipment and 3 to 5 years for computer software. Improvements to leased facilities are depreciated over the shorter of the remaining lease term or the anticipated life of improvement. |
n. | Recently Issued Accounting Pronouncements: In May 2014, the Financial Accounting Standards Board, or FASB, issued new guidance that amends the accounting for revenue recognition. The amendments are intended to provide a more robust framework for addressing revenue issues, improve comparability of revenue recognition practices, and improve disclosure requirements. Insurance contracts are not included in the scope of this new guidance. Accordingly, premiums revenue and investment income, collectively representing nearly 100% of consolidated revenues for the three and six months ended June 30, 2018, are not included in the scope of the new guidance. The Company adopted the new standard effective January 1, 2018, using the modified retrospective approach. As the majority of the Company’s revenues are not subject to the new guidance and the remaining revenues’ accounting treatment did not materially differ from pre-existing accounting treatment, the adoption of the new standard did not have a material impact on its consolidated results of operations, financial condition, cash flows, or disclosures. |
o. | Subsequent Events: The Company evaluated subsequent events through August 7, 2018, the date these financial statements were issued or available to be issued. |
3. | Investment Securities |
June 30, 2018 | ||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||
U.S. Treasury and agency obligations | $ | 21,344,400 | $ | 38,176 | $ | (453,455) | $ | 20,929,121 | ||||
U.S. Government and mortgage-backed securities | 37,012,865 | 31,453 | (1,513,020) | 35,531,298 | ||||||||
Tax-exempt municipal securities | 0 | 0 | 0 | 0 | ||||||||
Commercial mortgage-backed securities | 12,874,306 | 1,755 | (274,590) | 12,601,471 | ||||||||
Residential mortgage-backed securities | 4,133,256 | 19,511 | (311,584) | 3,841,183 | ||||||||
Asset backed securities | 2,064,809 | 134,517 | (5,899) | 2,193,427 | ||||||||
Corporate securities | 1,511,775,810 | 53,239,084 | (66,999,225) | 1,498,015,669 | ||||||||
Total investment securities | $ | 1,589,205,446 | $ | 53,464,496 | $ | (69,557,773) | $ | 1,573,112,169 |
December 31, 2017 | ||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||
U.S. Treasury and agency obligations | $ | 21,393,933 | $ | 524,104 | $ | (40,223) | $ | 21,877,814 | ||||
U.S. Government and mortgage-backed securities | 57,291,213 | 2,603,992 | (596,671) | 59,298,534 | ||||||||
Tax-exempt municipal securities | 2,282,928 | 92,140 | (22,722) | 2,352,346 | ||||||||
Commercial mortgage-backed securities | 13,049,371 | 129,047 | (50,838) | 13,127,580 | ||||||||
Residential mortgage-backed securities | 5,142,473 | 33,124 | (338,575) | 4,837,022 | ||||||||
Asset backed securities | 2,141,469 | 95,022 | (965) | 2,235,526 | ||||||||
Corporate securities | 2,025,061,564 | 219,851,386 | (11,425,497) | 2,233,487,453 | ||||||||
Total investment securities | $ | 2,126,362,951 | $ | 223,328,815 | $ | (12,475,491) | $ | 2,337,216,275 |
Amortized Cost | Fair Value | ||||
Due in one year or less | $ | 6,289,429 | $ | 6,279,619 | |
Due after one year through five years | 69,057,361 | 71,804,086 | |||
Due after five years through ten years | 96,811,943 | 98,094,759 | |||
Due after ten years | 1,360,961,477 | 1,342,766,326 | |||
Mortgage and asset-backed securities | 56,085,236 | 54,167,379 | |||
Total investment securities | $ | 1,589,205,446 | $ | 1,573,112,169 |
Three months ended June 30, | Six months ended June 30, | ||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||
Gross realized gains | $ | 55,413,360 | $ | 1,528,756 | $ | 42,071,211 | $ | 7,690,562 | |||
Gross realized losses | (1,376,117) | (574,274) | (671,642) | (1,256,179) | |||||||
Net realized gains | $ | 54,037,243 | $ | 954,482 | $ | 41,399,569 | $ | 6,434,383 |
June 30, 2018 | |||||||||||
Less Than 12 Months | 12 Months or More | Total | |||||||||
Fair | Unrealized | Fair | Unrealized | Fair | Unrealized | ||||||
Value | Losses | Value | Losses | Value | Losses | ||||||
U.S. Treasury and agency obligations | $ 17,101,215 | $ (452,202) | $ 149,156 | $ (1,253) | $ 17,250,371 | $ (453,455) | |||||
U.S. Government and mortgage-backed securities | 21,058,759 | (652,995) | 13,830,016 | (860,025) | 34,888,775 | (1,513,020) | |||||
Tax-exempt municipal securities | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Commercial mortgage-backed securities | 12,354,374 | (274,590) | 0 | 0 | 12,354,374 | (274,590) | |||||
Residential mortgage-backed securities | 589,969 | (12,652) | 2,458,347 | (298,932) | 3,048,316 | (311,584) | |||||
Asset-backed securities | 849,994 | (5,678) | 27,394 | (221) | 877,388 | (5,899) | |||||
Corporate securities | 695,436,056 | (33,962,496) | 205,300,203 | (33,036,729) | 900,736,259 | (66,999,225) | |||||
Total debt securities | $ 747,390,367 | $(35,360,613) | $221,765,116 | $ (34,197,160) | $ 969,155,483 | $ (69,557,773) |
December 31, 2017 | |||||||||||
Less Than 12 Months | 12 Months or More | Total | |||||||||
Fair | Unrealized | Fair | Unrealized | Fair | Unrealized | ||||||
Value | Losses | Value | Losses | Value | Losses | ||||||
U.S. Treasury and agency obligations | $ 8,719,821 | $ (35,711) | $ 1,304,912 | $ (4,512) | $ 10,024,733 | $ (40,223) | |||||
U.S. Government and mortgage-backed securities | 22,602,748 | (122,821) | 15,021,239 | (473,850) | 37,623,987 | (596,671) | |||||
Tax-exempt municipal securities | 0 | 0 | 260,207 | (22,722) | 260,207 | (22,722) | |||||
Commercial mortgage-backed securities | 1,994,844 | (50,838) | 0 | 0 | 1,994,844 | (50,838) | |||||
Residential mortgage-backed securities | 687,323 | (10,416) | 2,767,705 | (328,159) | 3,455,028 | (338,575) | |||||
Asset-backed securities | 824,219 | (563) | 29,546 | (402) | 853,765 | (965) | |||||
Corporate securities | 39,635,691 | (627,839) | 232,053,663 | (10,797,658) | 271,689,354 | (11,425,497) | |||||
Total debt securities | $ 74,464,646 | $ (848,188) | $ 251,437,272 | $ (11,627,303) | $ 325,901,918 | $ (12,475,491) |
4. | Fair Value |
June 30, 2018 | Fair Value Measurements Using | ||||||||||
Fair Value | Quoted Prices in Active Markets (Level 1) | Other Observable Inputs (Level 2) | Unobservable Inputs (Level 3) | ||||||||
Assets | |||||||||||
Cash equivalents | $ | 10,570,785 | $ | 10,570,785 | $ | 0 | $ | 0 | |||
Debt securities | |||||||||||
U.S. Treasury and agency obligations | 20,929,121 | 0 | 20,929,121 | 0 | |||||||
U.S. Government mortgage-backed securities | 35,531,298 | 0 | 35,531,298 | 0 | |||||||
Tax-exempt municipal securities | 0 | 0 | 0 | 0 | |||||||
Commercial mortgage-backed securities | 12,601,471 | 0 | 12,601,471 | 0 | |||||||
Residential mortgage-backed securities | 3,841,183 | 0 | 3,841,183 | 0 | |||||||
Asset backed securities | 2,193,427 | 0 | 1,878,355 | 315,072 | |||||||
Corporate securities | 1,498,015,669 | 0 | 1,497,222,862 | 792,807 | |||||||
Policy loans | 2,965,058 | 0 | 2,965,058 | 0 | |||||||
Mortgage loans | 943,151 | 0 | 943,151 | 0 | |||||||
Total investments | $ | 1,587,591,163 | $ | 10,570,785 | $ | 1,575,912,499 | $ | 1,107,879 |
December 31, 2017 | Fair Value Measurements Using | ||||||||||
Fair Value | Quoted Prices in Active Markets (Level 1) | Other Observable Inputs (Level 2) | Unobservable Inputs (Level 3) | ||||||||
Assets | |||||||||||
Cash equivalents | $ | 200,326,819 | $ | 200,326,819 | $ | 0 | $ | 0 | |||
Debt securities | |||||||||||
U.S. Treasury and agency obligations | 21,877,814 | 0 | 21,877,814 | 0 | |||||||
U.S. Government mortgage-backed securities | 59,298,534 | 0 | 59,298,534 | 0 | |||||||
Tax-exempt municipal securities | 2,352,346 | 0 | 2,352,346 | 0 | |||||||
Commercial mortgage-backed securities | 13,127,580 | 0 | 13,127,580 | 0 | |||||||
Residential mortgage-backed securities | 4,837,022 | 0 | 4,837,022 | 0 | |||||||
Asset backed securities | 2,235,526 | 0 | 1,920,454 | 315,072 | |||||||
Corporate securities | 2,233,487,453 | 0 | 2,232,546,752 | 940,701 | |||||||
Policy loans | 10,643,668 | 0 | 10,643,668 | 0 | |||||||
Mortgage loans | 1,215,866 | 0 | 1,215,866 | 0 | |||||||
Total investments | $ | 2,549,402,628 | $ | 200,326,819 | $ | 2,347,820,036 | $ | 1,255,773 |
For the three months ended June 30, | Asset Backed Securities | Corporate Securities | Total | |||||
Beginning balance at April 1, 2017 | $ | 374,094 | $ | 3,410,270 | $ | 3,784,364 | ||
Total gains or losses: | ||||||||
Realized in earnings | 0 | 0 | 0 | |||||
Unrealized in other comprehensive income | 8,098 | 28,618 | 36,716 | |||||
Purchases | 0 | 0 | 0 | |||||
Sales | 0 | 0 | 0 | |||||
Settlements | 0 | 0 | 0 | |||||
Amortization | 0 | 2,972 | 2,972 | |||||
Balance at June 30, 2017 | $ | 382,192 | $ | 3,441,860 | $ | 3,824,052 | ||
Beginning balance at April 1, 2018 | $ | 315,072 | $ | 799,155 | $ | 1,114,227 | ||
Total gains or losses: | ||||||||
Realized in earnings | 0 | 0 | 0 | |||||
Unrealized in other comprehensive income | 0 | (9,117) | (9,117) | |||||
Purchases | 0 | 0 | 0 | |||||
Sales | 0 | 0 | 0 | |||||
Settlements | 0 | 0 | 0 | |||||
Amortization | 0 | 2,769 | 2,769 | |||||
Balance at June 30, 2018 | $ | 315,072 | $ | 792,807 | $ | 1,107,879 |
For the six months ended June 30, | Asset Backed Securities | Corporate Securities | Total | |||||
Beginning balance at January 1, 2017 | $ | 382,192 | $ | 3,512,483 | $ | 3,894,675 | ||
Total gains or losses: | ||||||||
Realized in earnings | 0 | 0 | 0 | |||||
Unrealized in other comprehensive income | 0 | 31,653 | 31,653 | |||||
Purchases | 0 | 0 | 0 | |||||
Sales | 0 | 0 | 0 | |||||
Settlements | 0 | (114,739) | (114,739) | |||||
Amortization | 0 | 12,463 | 12,463 | |||||
Balance at June 30, 2017 | $ | 382,192 | $ | 3,441,860 | $ | 3,824,052 | ||
Beginning balance at January 1, 2018 | $ | 315,072 | $ | 940,701 | $ | 1,255,773 | ||
Total gains or losses: | ||||||||
Realized in earnings | 0 | 0 | 0 | |||||
Unrealized in other comprehensive income | 0 | (30,259) | (30,259) | |||||
Purchases | 0 | 0 | 0 | |||||
Sales | 0 | 0 | 0 | |||||
Settlements | 0 | (128,709) | (128,709) | |||||
Amortization | 0 | 11,074 | 11,074 | |||||
Balance at June 30, 2018 | $ | 315,072 | $ | 792,807 | $ | 1,107,879 |
5. | Income Taxes |
6. | Concentration of Risk |
7. | Related Party Transactions |
8. | Contingencies |
a. | Legal Proceedings: During the ordinary course of business, the Company is subject to pending and threatened legal actions. The Company records accruals for contingencies to the extent that the Company concludes it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The outcome of current or future litigation or governmental or internal investigations cannot be accurately predicted nor can the Company predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on the Company’s consolidated balance sheets, statements of income, and cash flows. |
b. | Economic Risks: General inflationary pressures may affect the costs of medical and other care, increasing the costs of claims expenses submitted by the Company. |
c. | Securities & Credit Markets Risks: Volatility or disruption in the securities and credit markets could impact the Company’s investment portfolio. The Company evaluates investment securities for impairment on a quarterly basis. There is a continuing risk that declines in fair value may occur and material realized losses from sales or other-than-temporary impairments may be recorded in future periods. |
d. | Penn Treaty: Penn Treaty is a financially distressed unaffiliated long-term care insurance company. On March 1, 2017, the Pennsylvania Commonwealth Court approved the liquidation of Penn Treaty. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, the Company may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as the Company. This court ruling triggered a guarantee fund assessment for the Company in the first quarter 2017. Based on current information, the assessment was estimated at approximately $2,300,000 with a remaining unpaid balance as of June 30, 2018 of $952,124. The assessment was discounted using a 3.5% discount rate and the undiscounted amount was approximately $3,300,000. The Company did not recognize any related premium tax offsets or policy surcharges. While the ultimate payment timing is currently unknown, the Company anticipates that the majority of the assessments will be paid within the next 5 years. |
• | Our historical unaudited consolidated financial statements, related notes, and the sections entitled Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Quarterly Report on Form 10-Q as of and for the six months ended June 30, 2018, filed on August 8, 2018. |
• | KMG’s historical unaudited consolidated financial statements and related notes as of and for the six months ended June 30, 2018 (filed herein as Exhibit 99.3). |
• | Our historical audited consolidated financial statements, related notes, and the sections entitled Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K as of and for the year ended December 31, 2017, filed on March 14, 2018. |
• | KMG’s historical audited consolidated financial statements and related notes as of and for the year ended December 31, 2017 (incorporated by reference as Exhibit 99.1 to HC2’s Current Report on Form 8-K, filed on May 3, 2018). |
• | Furrow’s historical unaudited condensed combined and carve-out interim financial statements and related notes as of and for the nine month periods ended September 30, 2017 and 2016, attached as Exhibit 99.2 to HC2's Current Report on Form 8-K, filed on December 19, 2017. |
HC2 HOLDINGS, INC. AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET As of June 30, 2018 (in thousands) | ||||||||||||||||||
Pro Forma Adjustments | Total Pro Forma | |||||||||||||||||
HC2 | KMG | KMG | Ref. | |||||||||||||||
Assets | (4a) | |||||||||||||||||
Investments: | ||||||||||||||||||
Fixed maturity securities, available-for-sale at fair value | $ | 1,249,253 | $ | 1,573,112 | $ | — | $ | 2,822,365 | ||||||||||
Equity securities | 79,557 | — | — | 79,557 | ||||||||||||||
Mortgage loans | 69,890 | 943 | — | 70,833 | ||||||||||||||
Policy loans | 17,768 | 2,965 | — | 20,733 | ||||||||||||||
Other invested assets | 86,109 | — | — | 86,109 | ||||||||||||||
Total investments | 1,502,577 | 1,577,020 | — | 3,079,597 | ||||||||||||||
Cash and cash equivalents | 112,304 | 578,242 | 188,329 | (6a) | 878,875 | |||||||||||||
Accounts receivable, net | 346,702 | 2,328 | — | 349,030 | ||||||||||||||
Recoverable from reinsurers | 531,269 | 817,843 | 33,200 | (6b) | 1,382,312 | |||||||||||||
Deferred tax asset | 991 | 168,812 | (168,812 | ) | (6c) | 991 | ||||||||||||
Property, plant and equipment, net | 368,914 | — | — | 368,914 | ||||||||||||||
Goodwill | 128,846 | — | — | 128,846 | ||||||||||||||
Intangibles, net | 120,280 | 56,992 | (56,992 | ) | (6d) | 120,280 | ||||||||||||
Other assets | 142,453 | 66,029 | — | 208,482 | ||||||||||||||
Total assets | $ | 3,254,336 | $ | 3,267,266 | $ | (4,275 | ) | $ | 6,517,327 | |||||||||
Liabilities, temporary equity and stockholders’ equity | ||||||||||||||||||
Life, accident and health reserves | $ | 1,728,167 | $ | 2,684,773 | $ | 199,627 | (6e) | $ | 4,612,567 | |||||||||
Annuity reserves | 237,373 | — | — | 237,373 | ||||||||||||||
Value of business acquired | 40,500 | — | 230,501 | (6f) | 271,001 | |||||||||||||
Accounts payable and other current liabilities | 296,339 | 13,446 | (2,861 | ) | (6g) | 306,924 | ||||||||||||
Deferred tax liability | 8,634 | — | 30,707 | (6h) | 39,341 | |||||||||||||
Debt obligations | 668,505 | — | — | 668,505 | ||||||||||||||
Other liabilities | 79,529 | 5,965 | — | 85,494 | ||||||||||||||
Total liabilities | 3,059,047 | 2,704,184 | 457,974 | 6,221,205 | ||||||||||||||
Commitments and contingencies | ||||||||||||||||||
Temporary equity | ||||||||||||||||||
Preferred stock | 26,325 | — | — | 26,325 | ||||||||||||||
Redeemable noncontrolling interest | 8,396 | — | — | 8,396 | ||||||||||||||
Total temporary equity | 34,721 | — | — | 34,721 | ||||||||||||||
Stockholders’ equity | — | — | ||||||||||||||||
Common stock | 45 | — | — | 45 | ||||||||||||||
Additional paid-in capital | 259,999 | 1,667,487 | (1,667,487 | ) | (6i) | 259,999 | ||||||||||||
Treasury stock, at cost | (2,434 | ) | — | — | (2,434 | ) | ||||||||||||
Accumulated deficit | (197,148 | ) | (1,092,105 | ) | 1,192,938 | (6j) | (96,315 | ) | ||||||||||
Accumulated other comprehensive income | (9,175 | ) | (12,300 | ) | 12,300 | (6k) | (9,175 | ) | ||||||||||
Total HC2 Holdings, Inc. stockholders’ equity | 51,287 | 563,082 | (462,249 | ) | 152,120 | |||||||||||||
Noncontrolling interest | 109,281 | — | — | 109,281 | ||||||||||||||
Total stockholders’ equity | 160,568 | 563,082 | (462,249 | ) | 261,401 | |||||||||||||
Total liabilities, temporary equity and stockholders’ equity | $ | 3,254,336 | $ | 3,267,266 | $ | (4,275 | ) | $ | 6,517,327 |
HC2 HOLDINGS, INC. AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS For the Six Months Ended June 30, 2018 (in thousands, except per share data amounts) | |||||||||||||||||||||||||
Pro Forma Adjustments | Financing Adjustments | Total Pro Forma | |||||||||||||||||||||||
HC2 | KMG | KMG | Ref. | Ref. | |||||||||||||||||||||
(4a) | |||||||||||||||||||||||||
Revenue | $ | 870,515 | $ | — | $ | — | $ | — | $ | 870,515 | |||||||||||||||
Life, accident and health earned premiums, net | 39,945 | 69,499 | (50,557 | ) | (7a) | — | 58,887 | ||||||||||||||||||
Net investment income | 37,066 | 48,565 | 349 | (7b) | — | 85,980 | |||||||||||||||||||
Net realized and unrealized gains on investments | 2,943 | 54,037 | — | — | 56,980 | ||||||||||||||||||||
Net revenue | 950,469 | 172,101 | (50,208 | ) | — | 1,072,362 | |||||||||||||||||||
Operating expenses | — | ||||||||||||||||||||||||
Cost of revenue | 776,283 | — | — | — | 776,283 | ||||||||||||||||||||
Policy benefits, changes in reserves, and commissions | 67,674 | 85,092 | (30,268 | ) | (7c) | — | 122,498 | ||||||||||||||||||
Selling, general and administrative | 109,143 | 25,551 | (20,147 | ) | (7d) | — | 114,547 | ||||||||||||||||||
Depreciation and amortization | 18,713 | 9,949 | (20,022 | ) | (7e) | — | 8,640 | ||||||||||||||||||
Other operating (income) expense, net | (2,067 | ) | — | — | — | (2,067 | ) | ||||||||||||||||||
Total operating expenses | 969,746 | 120,592 | (70,437 | ) | — | 1,019,901 | |||||||||||||||||||
Income (loss) from operations | (19,277 | ) | 51,509 | 20,229 | — | 52,461 | |||||||||||||||||||
Interest expense | (36,506 | ) | — | — | (4,079 | ) | (7k) | (40,585 | ) | ||||||||||||||||
Gain on sale of subsidiary | 102,141 | — | — | — | 102,141 | ||||||||||||||||||||
Income from equity investees | 5,521 | — | — | — | 5,521 | ||||||||||||||||||||
Other income (expenses), net | 124 | 5 | — | — | 129 | ||||||||||||||||||||
Income (loss) before income taxes | 52,003 | 51,514 | 20,229 | (4,079 | ) | 119,667 | |||||||||||||||||||
Income tax (expense) benefit | (11,093 | ) | (12,230 | ) | (4,248 | ) | (7f) | — | (7l) | (27,571 | ) | ||||||||||||||
Net income (loss) | 40,910 | 39,284 | 15,981 | (4,079 | ) | 92,096 | |||||||||||||||||||
Less: Net (income) loss attributable to noncontrolling interest and redeemable noncontrolling interest | (20,540 | ) | — | — | — | (20,540 | ) | ||||||||||||||||||
Net income (loss) attributable to HC2 Holdings, Inc. | 20,370 | 39,284 | 15,981 | (4,079 | ) | 71,556 | |||||||||||||||||||
Less: Preferred stock and deemed dividends from conversions | 1,406 | — | — | — | 1,406 | ||||||||||||||||||||
Net income (loss) attributable to common stock and participating preferred stockholders | $ | 18,964 | $ | 39,284 | $ | 15,981 | $ | (4,079 | ) | $ | 70,150 | ||||||||||||||
Income per common share | |||||||||||||||||||||||||
Basic | $ | 0.39 | $ | 1.43 | |||||||||||||||||||||
Diluted | $ | 0.38 | $ | 1.39 | |||||||||||||||||||||
Weighted average common shares outstanding | |||||||||||||||||||||||||
Basic | 44,114 | 44,114 | |||||||||||||||||||||||
Diluted | 45,284 | 45,284 |
HC2 HOLDINGS, INC. AND SUBSIDIARIES UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS For the Year Ended December 31, 2017 (in thousands, except per share data amounts) | ||||||||||||||||||||||||||||||||||
Pro Forma Adjustments | Financing Adjustments | Total Pro Forma | ||||||||||||||||||||||||||||||||
HC2 | KMG | Furrow | KMG | Ref. | Furrow | Ref. | Ref. | |||||||||||||||||||||||||||
(4a) | (4c) | |||||||||||||||||||||||||||||||||
Revenue | $ | 1,482,546 | $ | — | $ | 40,894 | $ | — | $ | — | $ | — | $ | 1,523,440 | ||||||||||||||||||||
Life, accident and health earned premiums, net | 80,524 | 156,058 | — | (120,259 | ) | (7a) | — | — | 116,323 | |||||||||||||||||||||||||
Net investment income | 66,070 | 97,579 | — | 684 | (7b) | — | — | 164,333 | ||||||||||||||||||||||||||
Net realized and unrealized gains on investments | 4,983 | 7,685 | — | — | — | — | 12,668 | |||||||||||||||||||||||||||
Net revenue | 1,634,123 | 261,322 | 40,894 | (119,575 | ) | — | — | 1,816,764 | ||||||||||||||||||||||||||
Operating expenses | — | — | — | |||||||||||||||||||||||||||||||
Cost of revenue | 1,313,069 | — | 42,140 | — | (8,116 | ) | (7g) | — | 1,347,093 | |||||||||||||||||||||||||
Policy benefits, changes in reserves, and commissions | 108,695 | 188,825 | — | (70,221 | ) | (7c) | — | — | 227,299 | |||||||||||||||||||||||||
Selling, general and administrative | 182,880 | 77,363 | 4,160 | (68,888 | ) | (7d) | (1,767 | ) | (7h) | — | 193,748 | |||||||||||||||||||||||
Depreciation and amortization | 31,315 | 27,248 | 6,482 | (47,394 | ) | (7e) | (1,428 | ) | (7i) | — | 16,223 | |||||||||||||||||||||||
Other operating (income) expense, net | (704 | ) | — | (6 | ) | — | — | — | (710 | ) | ||||||||||||||||||||||||
Total operating expenses | 1,635,255 | 293,436 | 52,776 | (186,503 | ) | (11,311 | ) | — | 1,783,653 | |||||||||||||||||||||||||
Income (loss) from operations | (1,132 | ) | (32,114 | ) | (11,882 | ) | 66,928 | 11,311 | — | 33,111 | ||||||||||||||||||||||||
Interest expense | (55,098 | ) | — | — | — | (636 | ) | (7j) | (11,100 | ) | (7k) | (66,834 | ) | |||||||||||||||||||||
Gain on contingent consideration | 11,411 | — | — | — | — | — | 11,411 | |||||||||||||||||||||||||||
Income from equity investees | 17,840 | — | — | — | — | — | 17,840 | |||||||||||||||||||||||||||
Other income (expenses), net | (12,772 | ) | 9 | (31 | ) | — | — | — | (12,794 | ) | ||||||||||||||||||||||||
Income (loss) before income taxes | (39,751 | ) | (32,105 | ) | (11,913 | ) | 66,928 | 10,675 | (11,100 | ) | (17,266 | ) | ||||||||||||||||||||||
Income tax (expense) benefit | (10,740 | ) | (85,484 | ) | (189 | ) | (23,425 | ) | (7f) | — | — | (7l) | (119,838 | ) | ||||||||||||||||||||
Net income (loss) | (50,491 | ) | (117,589 | ) | (12,102 | ) | 43,503 | 10,675 | (11,100 | ) | (137,104 | ) | ||||||||||||||||||||||
Less: Net (income) loss attributable to noncontrolling interest and redeemable noncontrolling interest | 3,580 | — | — | — | — | — | 3,580 | |||||||||||||||||||||||||||
Net income (loss) attributable to HC2 Holdings, Inc. | (46,911 | ) | (117,589 | ) | (12,102 | ) | 43,503 | 10,675 | (11,100 | ) | (133,524 | ) | ||||||||||||||||||||||
Less: Preferred stock and deemed dividends from conversions | 2,767 | — | — | — | — | — | 2,767 | |||||||||||||||||||||||||||
Net income (loss) attributable to common stock and participating preferred stockholders | $ | (49,678 | ) | $ | (117,589 | ) | $ | (12,102 | ) | $ | 43,503 | $ | 10,675 | $ | (11,100 | ) | $ | (136,291 | ) | |||||||||||||||
Basic and diluted loss per common share | $ | (1.16 | ) | $ | (3.18 | ) | ||||||||||||||||||||||||||||
Basic and diluted weighted average common shares outstanding | 42,824 | 42,824 |
1. | Description of the Transactions |
2. | Basis of Presentation |
4. | Conforming adjustments |
For the six months ended June 30, 2018 | Historical | Presentation Adjustment | Historical, as adjusted | Ref. | ||||||||||
Net premiums | $ | 69,499 | $ | (69,499 | ) | $ | — | 1 | ||||||
Life, accident and health earned premiums, net | $ | — | $ | 69,499 | $ | 69,499 | 1 | |||||||
Net investment and interest income | $ | 102,602 | $ | (102,602 | ) | $ | — | 1 | ||||||
Net investment income | $ | — | $ | 48,565 | $ | 48,565 | 1 | |||||||
Net realized and unrealized gains on investments | $ | — | $ | 54,037 | $ | 54,037 | 1 | |||||||
Net benefits expense | $ | 88,832 | $ | (88,832 | ) | $ | — | 1 | ||||||
Commission allowance on reinsurance ceded | $ | (3,741 | ) | $ | 3,741 | $ | — | 1 | ||||||
Policy benefits, changes in reserves, and commissions | $ | — | $ | 85,092 | $ | 85,092 | 1 | |||||||
Other revenue | $ | 5 | $ | (5 | ) | $ | — | 1 | ||||||
Other income (expenses) | $ | — | $ | 5 | $ | 5 | 1 |
As of June 30, 2018 | Historical | Presentation Adjustment | Historical, as adjusted | Ref. | ||||||||||
Debt securities, available for sale | $ | 1,553,702 | $ | (1,553,702 | ) | $ | — | 1 | ||||||
Restricted assets | $ | 19,435 | $ | (19,435 | ) | $ | — | 1 | ||||||
Fixed maturity securities, available-for-sale at fair value | $ | — | $ | 1,573,112 | $ | 1,573,112 | 1 | |||||||
Cash and cash equivalents | $ | 578,217 | $ | 25 | $ | 578,242 | 1 | |||||||
Intangibles, net | $ | 1,082 | $ | 55,910 | $ | 56,992 | 1 | |||||||
Current income tax receivable | $ | 2,281 | $ | (2,281 | ) | $ | — | 1 | ||||||
Other Assets | $ | 63,748 | $ | 2,281 | $ | 66,029 | 1 | |||||||
Prepaid Reinsurance Recoverable | $ | 55,910 | $ | (55,910 | ) | $ | — | 1 | ||||||
Benefits payable | $ | 58,003 | $ | (58,003 | ) | $ | — | 1 | ||||||
Future policy benefits payable | $ | 2,622,978 | $ | (2,622,978 | ) | $ | — | 1 | ||||||
Advance premiums | $ | 3,792 | $ | (3,792 | ) | $ | — | 1 | ||||||
Life, accident and health reserves | $ | — | $ | 2,684,773 | $ | 2,684,773 | 1 | |||||||
Book overdraft | $ | 3,546 | $ | (3,546 | ) | $ | — | 1 | ||||||
Due to Humana Inc. | $ | 3,271 | $ | (3,271 | ) | $ | — | 1 | ||||||
Accounts payable and other current liabilities | $ | 6,630 | $ | 6,816 | $ | 13,446 | 1 |
For the year ended December 31, 2017 | Historical | Presentation Adjustment | Historical, as adjusted | Ref. | ||||||||||
Net premiums | $ | 156,058 | $ | (156,058 | ) | $ | — | 1 | ||||||
Life, accident and health earned premiums, net | $ | — | $ | 156,058 | $ | 156,058 | 1 | |||||||
Net investment and interest income | $ | 105,264 | $ | (105,264 | ) | $ | — | 1 | ||||||
Net investment income | $ | — | $ | 97,579 | $ | 97,579 | 1 | |||||||
Net realized and unrealized gains on investments | $ | — | $ | 7,685 | $ | 7,685 | 1 | |||||||
Net benefits expense | $ | 190,819 | $ | (190,819 | ) | $ | — | 1 | ||||||
Commission allowance on reinsurance ceded | $ | (1,994 | ) | $ | 1,994 | $ | — | 1 | ||||||
Policy benefits, changes in reserves, and commissions | $ | — | $ | 188,825 | $ | 188,825 | 1 | |||||||
Other revenue | $ | 9 | $ | (9 | ) | $ | — | 1 | ||||||
Other income (expenses) | $ | — | $ | 9 | $ | 9 | 1 |
Year ended | ||
December 31, 2017 | ||
Average exchange rate ($ / £) | $1.29 | |
Period end exchange rate ($ / £) | NA(1) |
GBP | USD | ||||||||||||||||||||||
Historical | Presentation Adjustment | Historical, as adjusted | US GAAP Adjustments | US GAAP | US GAAP | ||||||||||||||||||
For the eleven months ended November 30, 2017 | Nine Months Ended September 30, 2017 | Two Months Ended November 30, 2017 | Ref. | Ref. | |||||||||||||||||||
(4b) | |||||||||||||||||||||||
Revenue | 30,243 | 1,501 | — | 31,744 | — | 31,744 | 40,894 | ||||||||||||||||
Third party costs | 24,572 | 1,207 | (25,779 | ) | — | 1 | — | — | — | ||||||||||||||
Cost of revenue | — | — | 28,070 | 28,070 | 1 | 4,641 | 2 | 32,711 | 42,140 | ||||||||||||||
Personnel expenses | 3,113 | 363 | (3,476 | ) | — | 1 | — | — | — | ||||||||||||||
Selling, general and administrative | — | — | 3,229 | 3,229 | 1 | — | 3,229 | 4,160 | |||||||||||||||
Depreciation and amortization | 4,858 | 174 | — | 5,032 | — | 5,032 | 6,482 | ||||||||||||||||
Other (income) | (9 | ) | — | 9 | — | 1 | — | — | — | ||||||||||||||
Other expenses | 1,822 | 226 | (2,048 | ) | — | 1 | — | — | — | ||||||||||||||
Other operating (income) expenses | — | — | (5 | ) | (5 | ) | 1 | — | (5 | ) | (6 | ) | |||||||||||
Net finance income / (expenses) | 165 | (6 | ) | (159 | ) | — | 1 | — | — | — | |||||||||||||
Other (expenses), net | — | — | 159 | 159 | 1 | (183 | ) | 3 | (24 | ) | (31 | ) | |||||||||||
Income tax (expense) benefit | (146 | ) | 1 | — | (145 | ) | — | (145 | ) | (189 | ) |
1. | Adjustment to reclassify historical Furrow financial statement presentation to HC2 financial statement presentation. |
2. | This adjustment reflects conversion from IFRS to US GAAP for Onerous Contract provision ("OCP"), for the Saltire cable-ship, a leased cable-ship within the Furrow business. This cable-ship was not acquired as part of the Furrow Acquisition. ASC paragraph 420-10-10-1 states that a liability for a cost associated with an exit or disposal activity is recognized and measured at fair value only when the liability has been incurred. Therefore, a liability for costs to terminate a contract before the end of its term shall be recognized when the entity terminates the contract in accordance with the contract terms. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity shall be recognized at the cease-use date. Therefore, a commitment to a plan and exit / cease of activities is not sufficient to recognize a liability. Also, future operating losses to be incurred in connection with an exit or disposal activity should be recognized when incurred. Using this criteria of US GAAP, the OCP does not meet the recognition criteria under US GAAP, until the moment that Furrow is committed to the termination of the lease contract. The cease-use criteria is also not met earlier as the Saltire cable-ship was used for projects until the summer of 2017. This commitment has been communicated in 2017. Therefore, the recognized onerous contract provision should be recognized 2017. In the period ended November 30, 2017 the OCP was not adjusted for under IFRS and should have been under US GAAP, therefore this adjustment reflects the costs incurred under US GAAP. |
3. | This adjustment reflects the reversal of Foreign Currency transaction expense as a result of the conversion of IFRS to US GAAP for the onerous contract provision. |
5. | Purchase Price Allocation |
Preliminary purchase price allocation | ||||
Fixed maturity securities, available-for-sale at fair value | $ | 1,573,112 | ||
Mortgage loans | 943 | |||
Policy loans | 2,965 | |||
Cash and cash equivalents | 766,581 | |||
Accounts receivable, net | 2,328 | |||
Recoverable from reinsurers | 851,043 | |||
Other assets | 66,028 | |||
Total assets acquired | 3,263,000 | |||
Life, accident and health reserves | 2,884,400 | |||
Value of business acquired | 230,501 | |||
Accounts payable and other current liabilities | 10,175 | |||
Deferred tax liability | 30,707 | |||
Other liabilities | 5,965 | |||
Total liabilities assumed | 3,161,748 | |||
Total net assets acquired | 101,252 | |||
Bargain purchase gain | (101,242 | ) | ||
Total fair value of consideration | $ | 10 |
• | The Unified Loss Rules ("ULR") tax attribute reduction to tax value of assets and the seller tax adjustments to tax value of liabilities contribute significantly to the bargain purchase price. |
• | The reduction in the federal income tax rate, from 35% at the time the seller contribution was established to 21% effective January 1, 2018, effectively generates the remaining balance for the bargain purchase price. |
• | Changes in fair value of acquired assets and assumed liabilities between the date the deal was signed and the closing date was driven by the time it took to obtain regulatory approvals, amongst other closing conditions. |
Year following the acquisition | ||||||||||||||||||||||||||
Fair Value | Estimated remaining useful life | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | ||||||||||||||||||||
VOBA | $ | 230,501 | 40 years | $ | (20,147 | ) | $ | (19,172 | ) | $ | (18,076 | ) | $ | (16,960 | ) | $ | (15,866 | ) | ||||||||
Benefit of fair value adjustment to acquire life accident and health reserves | $ | 150,662 | 40 years | (10,363 | ) | (11,045 | ) | (11,525 | ) | (11,397 | ) | (10,686 | ) | |||||||||||||
Total expected amortization, pre-tax | $ | (30,510 | ) | $ | (30,217 | ) | $ | (29,601 | ) | $ | (28,357 | ) | $ | (26,552 | ) | |||||||||||
Total expected amortization, after-tax | $ | (24,103 | ) | $ | (23,871 | ) | $ | (23,385 | ) | $ | (22,402 | ) | $ | (20,976 | ) |
Notes | $ | 7,500 | ||
Equity (43,882,283 Class A-2 Units of GMHL) | 79,735 | |||
Total Preliminary purchase price | $ | 87,235 |
(a) | A combination of the income approach and market approach was used to estimate the fair value of the stand-alone GMHL. A discounted cash flow analysis was used to estimate the enterprise value of Global Marine Holdings Limited based on projections prepared by GMHL's management. The weighted average cost of capital, used to discount the projected cash flows, was estimated utilizing public companies considered to be comparable to Global Marine Holdings Limited. |
(b) | The income approach was used to estimate the fair value of the Trenching Business. A discounted cash flow analysis was utilized to estimate the present value of future cash flows for the Trenching Business based on the expected life of the acquired assets, discounted at a rate of return that considered the relative risk of achieving those cash flows and the time value of money. |
(c) | The income approach was used to estimate the fair value of the synergies from the Furrow Acquisition. The synergies primarily relate to the stand-alone GMHL no longer needing to purchase the flagship vessel and trenchers, which were included in the stand-alone valuation of GMHL. |
Assets | ||||
Cash and cash equivalents | $ | 2,212 | ||
Property, plant and equipment | 73,320 | |||
Goodwill | 11,783 | |||
Other assets | 596 | |||
Total assets acquired | 87,911 | |||
Accounts payable and other current liabilities | 676 | |||
Total liabilities assumed | 676 | |||
Total net assets acquired | $ | 87,235 |
(a) | A combination of the income approach and market approach was used to estimate the Fugro Symphony vessel, considering, among other factors (i) estimates of the current market value of the vessel from a number of ship-brokers active in the offshore support vessel sector; (ii) a selection of comparable vessels that had recently been sold, or were being actively marketed for sale, along with the prices achieved / asking prices and; (iii) the current and future state of the market in which the vessel is expected to operate. A discounted cash flow analysis was completed to provide an estimate of the present value of estimated future cash flows for the expected life of the vessel, discounted at a rate of return that considered the relative risk of achieving those cash flows and the time value of money. |
(b) | A cost approach was used to estimate the fair value of the trenchers, considering, among other factors, the current quote for the construction of replacement assets and for estimated useful working life from the manufacturer of the trenchers. Additionally, a depreciated replacement cost of the assets was calculated. |
(c) | A combination of the cost approach and market approach was used to estimate the fair value of the ROVs, considering, among other factors, (i) estimates of replacement cost, estimated normal useful lives, and residual values from a number of subsea equipment manufacturers and brokers and; (ii) a selection of comparable new build and secondhand assets currently being marketed for sale. |
Year following the acquisition | ||||||||||||||||||||||||||
Fair Value | Estimated remaining useful life | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | ||||||||||||||||||||
Property, plant, and equipment | ||||||||||||||||||||||||||
Cable-ships and submersibles | $ | 71,018 | Various (1) | $ | 4,499 | $ | 3,851 | $ | 3,851 | $ | 3,851 | $ | 3,851 | |||||||||||||
Equipment | 2,302 | Various (2) | 663 | 663 | 663 | 63 | 63 | |||||||||||||||||||
Total expected depreciation (3) | $ | 73,320 | $ | 5,162 | $ | 4,514 | $ | 4,514 | $ | 3,914 | $ | 3,914 |
Increase (decrease) | ||||||
Assets | ||||||
(6a) | Adjustments to Cash and cash equivalents | |||||
This adjustment reflects a capital contribution to KIC prior to the closing of the KMG Acquisition. | $ | 191,610 | ||||
This adjustment reflects a settlement of historical intercompany payable between KIC and Humana. | (3,271 | ) | ||||
This adjustment reflects the purchase price paid by CGI at closing. | (10 | ) | ||||
$ | 188,329 | |||||
(6b) | Adjustments to Recoverable from reinsurers | |||||
This adjustment reflects Recoverable from reinsurers at fair value, driven by existing coinsurance agreements with Westport, GenRe, and Munich American Re that will persist after the closing date. KIC ceded 7.5% of the risk to Westport and Gen Re (combined coinsurance of 15%) for the early generation LTC products issued by KIC. The coinsurance agreement with Munich was for 50% - 60% of the risk on the later generation LTC products issued by KIC. | $ | 33,200 | ||||
(6c) | Adjustments to Deferred tax asset | |||||
This adjustment eliminates the historical deferred tax asset of KMG. | $ | (168,812 | ) | |||
(6d) | Adjustment to Intangibles, net | |||||
This adjustment reflects the exclusion of intangibles and deferred acquisition costs, net included within the historical KMG financial statements that are not included in the Acquisition. | $ | (56,992 | ) | |||
Total adjustments to assets | $ | (4,275 | ) |
June 30, 2018 | ||||||
Increase (decrease) | ||||||
Liabilities | ||||||
(6e) | Adjustments to Life, accident and health reserves at fair value | |||||
This adjustment reflects the elimination of historical reserves, due to PGAAP calculations. | $ | (2,684,773 | ) | |||
This adjustment reflects the fair value adjustment to gross up reserves because of existing coinsurance agreements with Westport, GenRe, and Munich American Re that will persist after the closing date. | 603,139 | |||||
This adjustment reflects the fair value adjustment to retained reserves due to PGAAP calculations and the post-close reserve increase expected driven from best estimate assumptions for the PGAAP calculations. | 2,281,261 | |||||
This adjustment reflects Life, accident and health reserves at fair value. | $ | 199,627 | ||||
(6f) | This adjustment reflects fair value of business acquired for PGAAP calculations. | $ | 230,501 | |||
(6g) | Adjustments to Accounts payable and other current liabilities | |||||
This adjustment reflects the transaction costs not reflected in the historical financial statements that are directly attributable to the KMG Acquisition and factually supportable and nonrecurring. | $ | 409 | ||||
This adjustment reflects a settlement of historical intercompany payable between KIC and Humana. | (3,270 | ) | ||||
$ | (2,861 | ) | ||||
(6h) | Adjustments to Deferred tax liability | |||||
This adjustment establishes the Deferred tax liability associated with the newly acquired entity. | $ | 30,707 | ||||
Total adjustments to liabilities | $ | 457,974 | ||||
Stockholders' equity | ||||||
(6i) | Adjustments to Additional paid-in capital | |||||
This adjustment reflects a capital contribution to KIC prior to the closing of the KMG Acquisition. | 191,610 | |||||
This adjustment reflects the elimination of historical equity of KMG and the impact of capital contributions to KIC prior to the closing of the KMG Acquisition. | (1,859,097 | ) | ||||
$ | (1,667,487 | ) | ||||
(6j) | Adjustments to Accumulated Deficit | |||||
This adjustment reflects the elimination of historical equity of KMG. | 1,092,105 | |||||
The adjustment represents preliminary bargain purchase gain, net of deferred tax, calculated as if the net assets were acquired on June 30, 2018. This bargain purchase gain is not reflected in the unaudited pro forma combined statements of operations because it is a nonrecurring item that is directly related to the transaction. | 101,242 | |||||
This adjustment reflects the transaction costs not reflected in the historical financial statements that are directly attributable to the KMG Acquisition and factually supportable and nonrecurring. | (409 | ) | ||||
$ | 1,192,938 | |||||
(6k) | Adjustments to Accumulated other comprehensive income (loss) | |||||
This adjustment reflects the elimination of historical fair value adjustments of KMG. | 16,093 | |||||
This adjustment reflects the elimination of the historical shadow reserves of KMG. | (3,793 | ) | ||||
$ | 12,300 | |||||
Total adjustments to stockholders' equity | $ | (462,249 | ) | |||
Total adjustments to liabilities and stockholders' equity | $ | (4,275 | ) |
June 30, 2018 | December 31, 2017 | |||||||||
Increase (decrease) | Increase (decrease) | |||||||||
(7a) | This adjustment reflects the Life, accident and health earned premiums, net included within the historical KMG financial statements generated by reserves that were ceded to Humana as part of the coinsurance agreement which was in place prior to the closing, and reflected in the June 30, 2018 historical financial statements of KMG. | $ | (50,557 | ) | $ | (120,259 | ) | |||
(7b) | Adjustment to net investment income to amortize the fair value adjustment to KMG's investments. | $ | 349 | $ | 684 | |||||
(7c) | Adjustments to Policy benefits, changes in reserves, and commissions | |||||||||
Adjustment to amortize the difference between the estimated fair value and the historical value of KMG's Life, accident, and health reserves. | (5,182 | ) | (10,363 | ) | ||||||
This adjustment reflects the Policy benefits, changes in reserves, and commissions included within the historical KMG financial statements generated by reserves that were ceded to Humana as part of the coinsurance agreement which was in place prior to the closing, and reflected in the June 30, 2018 historical financial statements of KMG. | (25,086 | ) | (59,858 | ) | ||||||
$ | (30,268 | ) | $ | (70,221 | ) | |||||
(7d) | Adjustment to Selling, general and administrative | |||||||||
This adjustment represents transaction costs that were recognized in the historical financial statements, and should be eliminated as they are nonrecurring charges that are directly attributable to the KMG Acquisition and do not reflect expenses of the combined entity on an ongoing basis. | (947 | ) | (2,529 | ) | ||||||
This adjustment reflects the Selling, general and administrative included within the historical KMG financial statements generated by reserves that were ceded to Humana as part of the coinsurance agreement which was in place prior to the closing, and reflected in the June 30, 2018 historical financial statements of KMG. | (19,200 | ) | (66,359 | ) | ||||||
$ | (20,147 | ) | $ | (68,888 | ) | |||||
(7e) | Adjustment to Depreciation and amortization expense | |||||||||
Adjustment to eliminate KMG's historical amortization of deferred acquisition costs following the write-off of the deferred policy acquisition costs asset. | (9,949 | ) | (27,248 | ) | ||||||
This adjustment reflects the amortization of VOBA due to the estimated fair value of in-force contracts being less than the amount recorded as insurance contract liabilities. | (10,073 | ) | (20,146 | ) | ||||||
$ | (20,022 | ) | $ | (47,394 | ) | |||||
(7f) | Adjustment to reflect the income tax impact on the unaudited pro forma adjustments. | $ | (4,248 | ) | $ | (23,425 | ) | |||
Impact of adjustments to Net Income (loss) | $ | 15,981 | $ | 43,503 |
December 31, 2017 | ||||||
Increase (decrease) | ||||||
(7g) | This adjustment reflects the exclusion of operations included within the historical Furrow financial statements that are not included in the Furrow Acquisition. Specifically an accrued lease termination expense associated with Saltire, a cable-ship which is included within the historical Furrow financial statements that is not included in the Furrow Acquisition. | $ | (8,116 | ) | ||
(7h) | This adjustment represents transaction costs that were recognized in the historical financial statements, and should be eliminated as they are nonrecurring charges that are directly attributable to the Furrow Acquisition and do not reflect expenses of the combined entity on an ongoing basis. | $ | (1,767 | ) | ||
(7i) | Adjustment to Depreciation and amortization expense | |||||
This adjustment reflects the elimination of historical depreciation expense associated with the Property, plant, and equipment of the Furrow business. | $ | (6,482 | ) | |||
This adjustment reflects the depreciation expense incurred as a result of the adjustment to record the Furrow Property, plant and equipment at fair value as a result of the preliminary Purchase Price Allocation. | 5,054 | |||||
$ | (1,428 | ) | ||||
(7j) | This adjustment reflects the net increase to interest expense resulting from interest on the loan GMSL incurred from a subsidiary of Fugro pursuant to the Vendor Loan Agreement. The loan matures within one year, and as such, is reflected in the proforma financial statements as if it were acquired on January, 1, 2017. | $ | 636 | |||
Impact of adjustments to Net Income (loss) | $ | 10,675 |
June 30, 2018 | December 31, 2017 | |||||||||
Increase (decrease) | Increase (decrease) | |||||||||
Interest Expense | ||||||||||
(7k) | Adjustment to reflect interest expense on the notes at 11% per annum | (4,235 | ) | (11,464 | ) | |||||
Adjustment to reflect amortization expense of original issue premium and deferred financing cost. | 156 | 364 | ||||||||
$ | (4,079 | ) | $ | (11,100 | ) | |||||
Income Tax | ||||||||||
(7l) | To reflect the income tax impact of the financing adjustments. (1) | $ | — | $ | — | |||||
Total financing adjustments to net loss | $ | (4,079 | ) | $ | (11,100 | ) |